Irfan Haq

1 Introduction Bleomycin, a chemotherapeutic agent commonly used in the ABVD regimen (adriamycin, bleomycin, vinblastine and dacarbazine) for Hodgkin's lymphoma, is associated with pulmonary toxicity in up to 18% of patients, with fetal forms occurring in approximately 4% [1]. The clinical presentation of bleomycin-induced lung injury (BILI) is variable and may mimic other lung diseases, often posing a diagnostic dilemma [2]. Prompt recognition and withdrawal of bleomycin are critical.

This case report features unique anaesthetic management of a patient with implanted deep brain stimulation (DBS) device undergoing abdominal surgery. It features the intraoperative measures taken for this patient for the implanted DBS. After turning off the DBS preoperatively, the patient showed an exaggerated sympathetic response which was very much resistant to medicines. It was unique to this patient that restarting the device alleviated refractory hypertension.